Medy-Tox086900
Medy-Tox (086900) Preliminary Earnings, Nov 10, 2026
Filing date ·
Medy-Tox reported preliminary Q3 2026 results (consolidated): Revenue of KRW 59.3 billion (-2.8% year over year), operating profit of KRW 15.5 billion (+74.5%…
Sign in to read this filing in detail
Continue to the filing details and any available analysis after signing in.
Filing lists and official source links are available without signing in.